Dangote Works With Scientists To Provide Ebola Vaccine

Dangote Works With Scientists To Provide Ebola Vaccine

We are delighted that the Dangote Foundation is
joining the Wellcome Trust and others in the
international consortium of funders to develop a
multi-pronged approach to combating Ebola.
“This is a fast-moving scene at present and it is
not yet clear precisely which partners will fund
which components of the work that we hope will
lead to new diagnostics, drugs and vaccines.
“What is more important is that the partners are all
not just talking about the problems, but actually
trying to make things happen and the future
inevitable epidemics. If things go well, we hope to
know whether this candidate vaccine is safe, with
some prospect of protecting people by Christmas.”
“The vaccine that is being tested in Oxford, and
then in The Gambia and Mali, is being given to the
consortium by NIH. It was originally developed by
a company called Okairos, which was taken over
by GSK last year.
“We are delighted that both NIH and GSK have
been very open to sharing the vaccine and
information about it with Oxford consortium,
recognizing that by sharing we can collectively
speed development